192 related articles for article (PubMed ID: 12229899)
1. A statin in every medicine cabinet?
Walsh MN
Health News; 2002 Sep; 8(9):3. PubMed ID: 12229899
[No Abstract] [Full Text] [Related]
2. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic trial of simvastatin versus fenofibrate in primary hypercholesterolemia].
Turki S; Mekaouer A; Kaabachi A; Ftouhi B; Mebazaa R; Ben Khalifa F
Tunis Med; 1994 Nov; 72(11):619-24. PubMed ID: 7762089
[No Abstract] [Full Text] [Related]
4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
5. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
6. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
8. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
9. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Mikhailidis DP; Wierzbicki AS
Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011
[No Abstract] [Full Text] [Related]
10. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
[No Abstract] [Full Text] [Related]
11. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients.
Pereira EC; Bertolami MC; Faludi AA; Sevanian A; Abdalla DS
Free Radic Biol Med; 2004 Nov; 37(9):1440-8. PubMed ID: 15454283
[TBL] [Abstract][Full Text] [Related]
12. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
13. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
16. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
[No Abstract] [Full Text] [Related]
17. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
Devroey D; Velkeniers B; Duquet W; Betz W
Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
[TBL] [Abstract][Full Text] [Related]
19. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG; Nilsson PM
Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
[No Abstract] [Full Text] [Related]
20. Experience with statin use in patients with chronic hepatitis C infection.
Gibson K; Rindone JP
Am J Cardiol; 2005 Nov; 96(9):1278-9. PubMed ID: 16253597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]